Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2020-09-01
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is hypothesized that lifelong endurance exercise may have beneficial effects on the circadian system stability and many, but not all health outcomes. Osteopenia/osteoporosis and low-grade malnutrition may be more prevalent in the group of endurance-trained senior runners.
In order to achieve the above research aims, sixty male subjects in total will be recruited according to inclusion and exclusion criteria. Four groups of subjects will differ according to their age and physical activity levels:
* a group of endurance-trained seniors (age range 65 - 75 year old, n=15) ● a group of sedentary seniors (age range 65 - 75 year old, n=15)
* a group of well endurance-trained young men (age range 20 - 30 year old, n=15) ● a group of sedentary young men (age range 20 - 30 year old, n=15).
Subjects must meet the following inclusion criteria:
1. for athletes' groups: defined as more than 150 minutes of running activity per week; for young athletes at least 3 years and for master athletes at least 15 years history of running.
2. for groups less active than recommended: no history of regular physical activity training and no more practice than 150 minutes of moderate or 75 minutes of vigorous intensity per week.
The standard inclusion criterion for every group will be body mass index (range 18.5-30 kg/m2).
No experimental study has been published on the potential of life-long exercise to attenuate the aging-induced disorganization of the circadian system and thus to promote healthy aging. In this aspect, the proposed study is original and up-to-date. Moreover, also other aspects of the study, e.g. exercise and inflammaging or the risks (besides the benefits) of the long-life endurance training on bone tissue etc. have been studied only scarcely. Therefore, more scientific information is needed before it can be safely prescribed to the aging population
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Time-specific Exercise in Circadian Context
NCT06746649
Ameliorating Effects of Aging by Physical Exercise
NCT05232968
Physical Activity Oxidative Stress and Inflammation With Ageing
NCT06980896
Effect of Two Years of Resistance Training on Health Status in Postmenopausal Women: Longitudinal Study Active Aging.
NCT06621368
Effect of Aerobic Training on Quality of Life in Elderly With Idiopathic Chronic Fatigue
NCT06203535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
master endurance athletes
men aged 65 to 75 with more than 150 minutes of running activity per week at least 15 years history of running
endurance running exercise
regular competitive or non-competitive running of medium and/or high intensity with the duration at least 20 minutes per session
elderly sedentary
men aged 65 to 75 with no history of regular physical activity training and no more practice than 150 minutes of moderate or 75 minutes of vigorous intensity per week according the ACSM recommendations
No interventions assigned to this group
young endurance athletes
men aged 20 to 30 with more than 150 minutes of running activity per week at least 3 years history of running
endurance running exercise
regular competitive or non-competitive running of medium and/or high intensity with the duration at least 20 minutes per session
young sedentary
men aged 20 to 30 with no history of regular physical activity training and no more practice than 150 minutes of moderate or 75 minutes of vigorous intensity per week according the ACSM recommendations
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
endurance running exercise
regular competitive or non-competitive running of medium and/or high intensity with the duration at least 20 minutes per session
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* more than 150 minutes of running activity which is by ACSM considered as vigorous intensity of endurance running for young athletes at least 3 years and for master athletes at least 15 years
* body mass index (BMI index) - range 18.5-30 kg/m2
for groups less active than recommended (sedentary young and elderly)
* no history of regular physical activity training and no more practice than 150 minutes of moderate or 75 minutes of vigorous intensity per week
* body mass index (BMI index) - range 18.5-30 kg/m2
Exclusion Criteria
* malignant disease
* uncontrolled hypertension (higher than 160 / 95mmHG)
* congestive heart failure (NYHA grade III and IV)
* unstable angina pectoris
* recent myocardial infarction (during the last 6 months)
* severe cardiac arrhythmia (anamnestic)
* chronic obstructive pulmonary disease
* presence of severe pulmonary, pleural or pericardial disease
* severe asthma
* recent sudden stroke (during the last 6 months)
* epilepsy
* insulin-dependent diabetes mellitus
* unstable bone lesions with a high risk of fractures
* other chronic diseases, at the discretion of the responsible doctor
* states of mental incompetence (severe anxiety and depression, dementia, alcoholism , or other dependencies, mental retardation)
* conditions complicating regular physical activity (uncontrollable pain, severe arthritis, planned knee / hip endoprosthesis, pathological fractures (last 6 months), amputation, use of walker, wheelchair
* pharmacological interference (e.g., steroids, nonsteroidal anti-inflammatory agents, immunosuppressive and antineoplastic drugs, beta blockers, statins)
* the use of performance-enhancing drugs in the past and during the study period
20 Years
75 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Physiko- und Rheumatherapie Gesellschaft m.b.H.
UNKNOWN
University of Padova
OTHER
University of Roma La Sapienza
OTHER
University of Primorska
OTHER
Comenius University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ján Cvečka, PhD.
Role: PRINCIPAL_INVESTIGATOR
Comenius University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comenius University in Bratislava, Faculty of physical education and sport Bratislava, Slovakia
Bratislava, , Slovakia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
305041X157
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.